Syncom: New Chairman Expands Business Scope, Alters Documents
Syncom Formulations (India) Limited shareholders approved several alterations to the company's Articles of Association (AOA) and Memorandum of Association (MOA) during their 37th Annual General Meeting on September 29, 2025. The changes include inserting new Articles 2(j), 2(k), 15(3), and 15(4) into the AOA, and substituting Article 118 with a new version.
Article 2(j) introduces "Power Purchase Agreement and wheeling agreement (WA)" to define arrangements for electricity supply to captive users or third parties. Article 2(k) defines "Project/s" related to solar, solar-wind hybrid, and other power plants for electricity supply or sale. Article 15(3) details the company's power to issue sweat equity shares, while Article 15(4) pertains to Employee Stock Option Schemes (ESOPs). The new Article 118 outlines provisions for shareholders to waive or forgo their right to receive dividends.
The MOA also saw alterations, with the substitution of existing Clause 2 and the insertion of new Clauses 6 and 7 under the main Object Clause (III)(A). The new clauses expand the company's business to include manufacturing and trading nutraceuticals, dietary supplements, herbal and ayurvedic preparations, and real estate development.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Syncom Formulations (India) publishes news
Free account required • Unsubscribe anytime